MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference
MediWound (NASDAQ:MDWD) CEO Ofer Gonen provided an update on the company's commercial burn franchise, late-stage chronic wound program, manufacturing expansion plans, and government-related efforts...